We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
CM
126
CS McKee
Pennsylvania
$64.6M -$5.26M -23,518 -8%
BNP Paribas Asset Management
127
BNP Paribas Asset Management
France
$62.8M +$2.42M +10,797 +4%
RIM
128
Rainier Investment Management
Washington
$61.7M +$57.2M +255,796 New
SCM
129
Suvretta Capital Management
New York
$59.7M -$8.93M -39,900 -14%
Loomis, Sayles & Company
130
Loomis, Sayles & Company
Massachusetts
$58.3M +$54M +241,496 New
CPM
131
Chesapeake Partners Management
Maryland
$58.1M +$18.1M +81,091 +51%
GF
132
Gabelli Funds
New York
$56.8M -$940K -4,200 -2%
Balyasny Asset Management
133
Balyasny Asset Management
Illinois
$56.7M +$25.8M +115,221 +96%
JCI
134
Jet Capital Investors
New York
$56.7M +$52.6M +235,000 New
Bank of Montreal
135
Bank of Montreal
Ontario, Canada
$55.5M +$16.1M +71,992 +46%
CIP
136
Chartwell Investment Partners
Pennsylvania
$55.4M -$408K -1,825 -0.8%
HSBC Holdings
137
HSBC Holdings
United Kingdom
$53.4M +$37.9M +169,386 +325%
CC
138
Cannell & Co
New York
$53.4M +$49.5M +221,080 New
KI
139
Kalmar Investments
Delaware
$52.6M
MDSL
140
M.D. Sass LLC
New York
$52M -$26.4M -117,810 -35%
TAM
141
Tocqueville Asset Management
New York
$51.9M +$28.7M +128,399 +148%
SAM
142
Steinberg Asset Management
New York
$50.1M -$455K -2,033 -1%
NFA
143
Nationwide Fund Advisors
Ohio
$49.4M +$30.4M +135,986 +198%
Chevy Chase Trust
144
Chevy Chase Trust
Maryland
$49M +$16.9M +75,707 +60%
AC
145
Apex Capital
California
$48.3M -$16.8M -75,000 -27%
SIM
146
Sadoff Investment Management
Wisconsin
$47.6M -$1.73M -7,710 -4%
TCSAM
147
Tyrus Capital S.A.M.
Monaco
$47M -$62.3M -278,600 -59%
ZDA
148
Zweig-DiMenna Associates
New York
$46.9M -$3.38M -15,123 -7%
IGIM
149
I.G. Investment Management
Manitoba, Canada
$45.2M +$6.19M +27,642 +17%
CAM
150
Cacti Asset Management
Georgia
$44M +$40.8M +182,378 New

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.